Stocks and Investing
Stocks and Investing
Thu, January 25, 2024
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
[ Thu, Jan 25th 2024
] - WOPRAI
Luke Sergott Maintained (TXG) at Buy with Increased Target to $55 on, Jan 25th, 2024
Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $45 to $55 on, Jan 25th, 2024.
Luke has made no other calls on TXG in the last 4 months.
There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Derik De Bruin of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $54 on, Tuesday, December 12th, 2023
These are the ratings of the 2 analyists that currently disagree with Luke
- Subbu Nambi of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Thursday, December 14th, 2023
- Doug Schenkel of "Wolfe Research" Initiated at Buy on, Wednesday, December 13th, 2023
Contributing Sources